AMETEK Inc (AME):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:AMETEK Inc (AME) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6534
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AMETEK Inc (AMETEK) is an electronic products manufacturing company that manufactures electronic instruments and electromechanical devices. The company’s products include medical materials, motion control systems, sub assemblies and connectors, electrical cord reels, gauges, titanium alloys and others. It also provides UPS systems, power inverters, engine and aircraft condition monitoring systems, upstream, midstream and downstream oil and gas production products. AMETEK offers electronic cable assemblies, heavy vehicle custom instrumentation, polymers, resins, engineered connectors, motors, blowers and pumps for transportation and others. The company serves medical, aerospace and defense, power and oil and gas industries. It has its operations in the Americas, Europe, and Asia. AMETEK is headquartered in Berwyn, Pennsylvania, the US.

AMETEK Inc (AME) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AMETEK Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
AMETEK Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
AMETEK Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
AMETEK Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
AMETEK Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
AMETEK Inc, Medical Equipment, Deal Details 10
Partnerships 10
AMETEK Enters into Agreement with LEPA-EPFL 10
Debt Offering 11
AMETEK Raises USD100 Million in Private Placement of 3.96% Notes Due 2025 11
AMETEK Raises USD50 Million in Private Placement of 3.91% Notes Due 2025 12
AMETEK Raises USD300 Million in Private Placement of 3.73% Notes Due 2024 13
AMETEK Raises USD100 Million in Private Placement of 3.83% Notes Due 2026 14
AMETEK Raises USD100 Million in Private Placement of 3.98% Notes Due 2029 15
Acquisition 16
Ametek Completes Acquisition of Zygo for USD280 Million 16
Ametek Acquires Creaform For US$115 Million 17
Ametek Completes Acquisition Of Dunkermotoren From Triton Advisers For US$330 Million 19
AMETEK Acquires Technical Manufacturing, Scientific Instrument Company 20
AMETEK Inc – Key Competitors 21
AMETEK Inc – Key Employees 22
AMETEK Inc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 26
Financial Announcements 26
Jul 31, 2018: AMETEK announces record second quarter results and raises 2018 guidance 26
May 02, 2018: AMETEK reports financial results for three month period ended March 31, 2018 27
May 02, 2018: AMETEK Announces Record First Quarter Results And Raises 2018 Guidance 28
Feb 01, 2018: AMETEK Announces Record Fourth Quarter and Full Year Results and Issues 2018 Guidance 29
Corporate Communications 30
Aug 03, 2018: John Mockler elected Vice President, International Human Resources 30
May 09, 2018: AMETEK names Matthew Conti as vice president, human resources 31
May 09, 2018: AMETEK hires David Samyn as vice president and general manager for materials analysis division 32
Feb 20, 2018: Mark Scheuer Elected Vice President, Environmental, Health & Safety 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
AMETEK Inc, Medical Equipment, Key Facts, 2017 2
AMETEK Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
AMETEK Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
AMETEK Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
AMETEK Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
AMETEK Inc, Deals By Market, 2012 to YTD 2018 8
AMETEK Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
AMETEK Enters into Agreement with LEPA-EPFL 10
AMETEK Raises USD100 Million in Private Placement of 3.96% Notes Due 2025 11
AMETEK Raises USD50 Million in Private Placement of 3.91% Notes Due 2025 12
AMETEK Raises USD300 Million in Private Placement of 3.73% Notes Due 2024 13
AMETEK Raises USD100 Million in Private Placement of 3.83% Notes Due 2026 14
AMETEK Raises USD100 Million in Private Placement of 3.98% Notes Due 2029 15
Ametek Completes Acquisition of Zygo for USD280 Million 16
Ametek Acquires Creaform For US$115 Million 17
Ametek Completes Acquisition Of Dunkermotoren From Triton Advisers For US$330 Million 19
AMETEK Acquires Technical Manufacturing, Scientific Instrument Company 20
AMETEK Inc, Key Competitors 21
AMETEK Inc, Key Employees 22
AMETEK Inc, Subsidiaries 23

List of Figures
AMETEK Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
AMETEK Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
AMETEK Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
AMETEK Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
AMETEK Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
AMETEK Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
AMETEK Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
AMETEK Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[AMETEK Inc (AME):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pluristem Therapeutics Inc (PSTI):企業の財務・戦略的SWOT分析
    Summary Pluristem Therapeutics Inc (Pluristem) is a clinical-stage biotherapy company that focuses on the development of placental-derived cell therapies. Its PLacental eXpanded (PLX) cells are adherent stromal cells that can be administered to patients without tissue or genetic matching. The compan …
  • Yakult Honsha Co., Ltd.:企業の戦略・SWOT・財務分析
    Yakult Honsha Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Yakult Honsha Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Interpace Biosciences Inc (IDXG):企業の製品パイプライン分析
    Summary Interpace Biosciences Inc (Interpace Biosciences) formerly Interpace Diagnostics Group Inc, is a developer of molecular diagnostics tests. The company offers PancraGen, a DNA based molecular test that aids in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its pathf …
  • Molecular Warehouse Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Molecular Warehouse Ltd (Molecular Warehouse) is a developer of proteins for diagnostic and therapeutic use. The company helps prevent diseases by empowering people with molecular diagnostics. Its synthetic biology techniques enabled it to reengineer glucose dehydrogenase, and enzymes found …
  • TyraTech Inc (TYR):企業の財務・戦略的SWOT分析
    Summary TyraTech Inc (TyraTech) is a clean technology and life science company that manufactures, markets, and develops insect and parasite control products. The company offers products such as equine fly spray, head lice solutions, insect repellent, insect and parasite products, and production anim …
  • Duraloy Technologies Inc:企業の戦略的SWOT分析
    Duraloy Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • PPL Corp (PPL):石油・ガス:M&Aディール及び事業提携情報
    Summary PPL Corp (PPL) is an energy holding company. Through its subsidiaries, LG&E, Kentucky Utilities, and KU Energy, it generates, transmits, distributes, and sells electricity; and distributes and sells natural gas. The company produces electricity from coal, natural gas, oil, hydro, and solar s …
  • Caldera Health Ltd:企業の製品パイプライン分析2018
    Summary Caldera Health Ltd (Caldera) is a biotech company that develops prostate cancer diagnostic tools. The company offers prostate cancer diagnostic and prognostic tests to detect and monitor the cancer disease. It has developed a laboratory test that measures the expression of a range of RNA bio …
  • University of York-製薬・医療分野:企業M&A・提携分析
    Summary University of York (York) is an educational and research university that offers academic research and teaching services. The university offers commercial facilities and services, funding collaborative research, knowledge transfer partnerships, professional development and training, consultan …
  • R. R. Donnelley & Sons Co (RRD):企業の財務・戦略的SWOT分析
    R. R. Donnelley & Sons Co (RRD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • BNP Paribas SA:企業のM&A・事業提携・投資動向
    BNP Paribas SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BNP Paribas SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Amphenol Corp (APH):企業の財務・戦略的SWOT分析
    Amphenol Corp (APH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Phoenix Children’s Hospital-製薬・医療分野:企業M&A・提携分析
    Summary Phoenix Children's Hospital (PCH) is a healthcare center that provides medical services. The center’s services include anestesiology, dermatology, dermatology, child protection, bone marrow transplants, adolescent medicine, critical care, emergency medicine, developmental paediatrics and fet …
  • Fresenius SE & Co KGaA (FRE):医療機器:M&Aディール及び事業提携情報
    Summary Fresenius SE & Co KGaA (Fresenius) is a global health care group, which offers products and services for dialysis treatment. It provides various dialysis services through its own clinics and sells its products to other dialysis service providers. Its major products and services includes mach …
  • Santos Ltd (STO):企業の財務・戦略的SWOT分析
    Santos Ltd (STO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • J.M. Huber Corporation:企業の戦略・SWOT・財務情報
    J.M. Huber Corporation - Strategy, SWOT and Corporate Finance Report Summary J.M. Huber Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Citrix Systems Inc (CTXS):企業の財務・戦略的SWOT分析
    Citrix Systems Inc (CTXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Coca-Cola Amatil Limited:企業の戦略・SWOT・財務情報
    Coca-Cola Amatil Limited - Strategy, SWOT and Corporate Finance Report Summary Coca-Cola Amatil Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • 3-V Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary 3-V Biosciences Inc (3-V Biosciences) is a clinical-stage pharmaceutical company that develops novel therapeutics in metabolic diseases. The company offers TVB-2640, a fatty acid synthase inhibitor used for the treatment of solid tumors, including non-small cell lung cancer (NSCLC), breast c …
  • Daniel Thwaites Plc:企業の戦略・SWOT・財務分析
    Daniel Thwaites Plc - Strategy, SWOT and Corporate Finance Report Summary Daniel Thwaites Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆